ArticleVaccine2025

Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice.

Rebecca L Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.